Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
CBI Research, Inc.
CBI and PharmaVoice Announce Recipients of the Strategic Patient Adherence Awards
May 12th, 2008
AstraZeneca, Eli Lilly and Rx Canada received top honors at the 2008 Strategic Patient Adherence (SPA) Awards. Rx Canada and their client (AstraZeneca Canada), the first international award winners, received awards for the Best Branded Compliance Program. The Health Inform(R) Programs for Crestor, Symbicort and Nexium medications were lauded for measurement of each program's effectiveness. "I really liked the way in which they measured and published their results," said Robert Nauman, BioPharma Advisors and a judge for the SPA awards. Rx Canada and their client (Eli Lilly Canada) received an innovation award for the Evista Inner Strength Program which ensured that pharmacists followed up...
Source: Biotech Business Week (2008-05-12)
|
